Beli & Jual Bundamedik Tbk - BMHS Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| Revenue | Rp1,15 T | -0.18% |
| Cost of Revenue | Rp616,57 M | +0.79% |
| Gross Profit | Rp538,32 M | -1.26% |
| General Expenses, Depreciation, Interest | Rp468,75 M | -0.75% |
| Operating Profit | Rp69,57 M | -4.58% |
| Other Income | -Rp43,43 M | -7.64% |
| EBT | Rp26,13 M | +0.99% |
| Taxes | -Rp6,12 M | -207.36% |
| Net Income | Rp12,25 M | +3.85% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| Total Assets | Rp3,64 T | -3.67% |
| Total Liabilities | Rp1,48 T | -8.46% |
| Total Equity | Rp1,72 T | +7.6% |
| Total Liabilities & Total Equity | Rp3,2 T | -0.48% |
Cash Flow
Operating
Investing
Finance
Net CF
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| CF from Operations | Rp50,98 M | +47.31% |
| CF from Investment | Rp102,53 M | -49.06% |
| CF from Financing | Rp78,9 M | -88.68% |
| Net Cash Flow | Rp27,35 M | -94.84% |